Professor Deng Yue's clinical experience of applying Huotan Jiedu Tongluo Formula in the treatment of residual risk after percutaneous coronary intervention based on the theory of"dosage and syndrome cor-respondence"
At present,traditional Chinese medicine doctors basically follow the principle of"formula and syndrome correspondence"in diagnosis and treatment of diseases,but the"dosage and syndrome correspondence"is easily ignored in clinical diagnosis.Based on the theory of"phlegm stasis hidden pathogen",Professor Deng Yue shares the experience of applying Huotan Jiedu Tongluo Formula in the treatment of residual risk after percutaneous coronary intervention for coronary heart disease,and analyzes the causes and pathogenesis of the disease from a deeper dimension,and stresses that the goal of improving long-term prognosis and quality of life of patients should be taken as the goal when traditional Chinese medicine is used to treat residual cardiovascular risk.Paying attention to the adjustment of dosage forms is helpful to improve clinical efficacy and reduce economic burden in the treatment of this disease.Based on this consideration,the sequential treatment plan of traditional Chinese medicine with decoction-pills for residual risk after percutaneous coronary intervention is proposed,aiming at providing clinical guidance for further reducing atherosclerotic cardiovascular disease events.
Phlegm stasis hidden pathogenPercutaneous coronary interventionResidual riskTraditional Chinese medicineDosage and syndrome correspondence
NETL
NSTL
万方数据
